Volume 7 Supplement 2

23rd International Symposium on Intensive Care and Emergency Medicine

Open Access

Bioelectrical impedance analysis as a predictor for survival in patients with systemic inflammatory response syndrome

  • S Swaraj1,
  • G Marx1,
  • G Masterson2 and
  • M Leuwer1
Critical Care20037(Suppl 2):P185


Published: 3 March 2003


Noninvasive bioelectrical impedance analysis (BIA) measures resistance, reactance and the derived phase angle (phi, degrees). A low phase angle has been associated with an altered cellular membrane function [1]. In septic shock patients, a phase angle of less than 4° has been reported to be associated with increased mortality [2]. Furthermore a low phase angle was highly correlated with mortality in patients with AIDS [3] and burns [4]. In our study we examined the prognostic value of the phase angle using BIA in patients with systemic inflammatory response syndrome (SIRS).


Prospective clinical observational study.


Thirty consecutive patients (11 female, 19 male, median age of 67 [16.5] years) were included after admission to the intensive care unit, all of whom met two or more SIRS criteria. SIRS was defined using the criteria suggested by ACCP/SCCM guidelines. Severity of illness was characterised according to the Acute Physiology and Chronic Health Evaluation (APACHE) II. Noninvasive impedance analysis was performed using a tetra polar hand-to-foot BIA measuring device (BIA 2000, Data input) as resistance (Ohms) and reactance (Ohms). The derived phase angle was calculated as arc tan(reactance/resistance). Two diagnostic electrodes were attached to the hand and two diagnostic electrodes were attached to the ipsilateral foot. All measurements were performed in supine position of the patient with special care taken that arms and legs did not touch the rest of the body or any grounding object. The joints were semiflexed. Data are presented as median and interquartile range (IQR). Fisher's exact test was performed to compare a phase angle of more than 4° at inclusion day with the 28 day mortality and APACHE II scores between survivors and nonsurvivors. P < 0.05 was considered significant.


After 28 days, out of the 30 patients investigated 10 had died and 20 were survivors. The APACHE II score on inclusion day of the survivors was 11 (7.0) compared with 16 (6.8) in nonsur-vivors (P = 0.87). In seven out of the 20 survivors a phase angle of more than 4° was measured on the first study day, whereas in all patients who died the phase angle was smaller than 4° (P = 0.038).


These results demonstrate that, in patients developing SIRS, an initial phase angle of more than 4° may be significantly correlated with survival.

Authors’ Affiliations

University Department of Anaesthesia, University of Liverpool
Department of Intensive Care, Royal Liverpool University Hospital


  1. Mattar JA: New Horiz 1996, 4: 493-503.PubMedGoogle Scholar
  2. Marx G, et al.: Intensive Care Med 2000, 26: 1252-1258. 10.1007/s001340000601View ArticlePubMedGoogle Scholar
  3. Ott M, et al.: J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9: 20-25.View ArticlePubMedGoogle Scholar
  4. Zdolsek HJ, et al.: Burns 1998, 24: 233-240. 10.1016/S0305-4179(98)00016-3View ArticlePubMedGoogle Scholar


© BioMed Central Ltd 2003